State of the art research and development and pre-clinical and clinical trials for Prolon® were conducted at the University of Southern California’s Longevity Institute and Diabetes and Obesity Research Institute, and sponsored by the National Cancer Institutes (NCI) and National Institute on Aging (NIA) of the National Institute of Health (NIH).
The results of the above research were published in top scientific peer-reviewed journals.
Science Translational Medicine
Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease.
Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality
Enhancing stem cell transplantation with “Nutri-technology”.
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
Safety and feasibility of fasting in combination with platinum-based chemotherapy
Dietary Interventions, Cardiovascular Aging, and Disease Animal Models and Human Studies
A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.
A periodic diet that mimics fasting and promotes multi-system regeneration, enhanced cognitive performance, and health span.
Fasting: Molecular Mechanisms and Clinical Applications
Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer’s disease mouse model.
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.
Fasting enhances the response of glioma to chemo- and radiotherapy.
The statements on this site have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*Individual results may vary.
Your feedback has been received.